Abstract

Cystic fibrosis (CF) is associated with the emergence of CF-related diabetes (CFRD). CFRD is associated with increased risk of accelerated weight and/or lung function loss (clinical degradation). Data in the CF pediatric population reported an association between higher 60-min oral glucose tolerance test (OGTT) plasma glucose values and reduced lung function. Our objective was to evaluate the relationship between the 60-min OGTT insulin and glucose values and markers of clinical degradation in adult patients with CF. This study was based on an ongoing observational cohort of CF adult patients (≥18years). All patients underwent a 2-h OGTT with 30-min interval sample measurements. Plasma insulin and glucose levels were measured. Adult patients (N=240) were categorized based on the 60-min OGTT median values of glucose (G60, 11.0mmol/L) and/or insulin (I60, 43.4μU/mL). A negative association was observed between the 60-min OGTT glucose value and pulmonary function (FEV1; P=0.001), whereas 60-min OGTT insulin values were positively associated with BMI (P=0.004). Patients with high G60 values displayed lower FEV1 than patients with low G60 values (P=0.025). Patients with higher I60 values demonstrated higher values of both FEV1 (P=0.022) and BMI (P=0.003) than patients with low I60 values. More importantly, when adjusting for BMI, the difference in FEV1 between both groups no longer existed (P=0.166). Both insulin and glucose values at 60-min OGTT are associated with indicators of clinical degradation in adult patients with CF. Future prospective analyses are essential in establishing the clinical utility of these indicators.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call